← FDA Drug Approvals (Drugs@FDA)

ENTEREG

NDA · New Drug Application · Sponsor: CUBIST PHARMS · Approved 2008-05-20

Drug application

FDA Application #

NDA021775

Application type

New Drug Application

Brand name

ENTEREG

Generic name

Alvimopan

Active ingredients

ALVIMOPAN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

CUBIST PHARMS

First approval

2008-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown